Cardiol Therapeutics: First-Mover In CBD-Based Treatment For Heart Disease
Cardiol Therapeutics (CRDL) (CRDL.CA) is a clinical-stage life sciences company focused on anti-inflammatory therapies for heart disease. The company's lead drug, CardiolRx™, is undergoing clinical trials for treating Pericarditis and Myocarditis. It is a THC-free (<10 ppm) pharmaceutically produced ultra-pure, high-concentration cannabidiol oral formul…
Keep reading with a 7-day free trial
Subscribe to Microcap Opportunities to keep reading this post and get 7 days of free access to the full post archives.